Miyata H, Himeno K, Nomoto K
Cancer Res. 1983 Oct;43(10):4670-5.
Meth A fibrosarcoma-bearing BALB/c mice given intratumoral injections of 0.5 mg of Corynebacterium parvum showed a highly and tumor-specific transplantation antigen specifically potentiated concomitant immunity to a subsequent tumor challenge. This potentiated antitumor immunity could be locally transferred in the Winn assay to normal recipients with whole draining lymph node cells from the tumor-bearing mice, but the potentiated effect disappeared when adherent cells were removed from these cells. Moreover, the potentiated cytostatic effect on tumor cells was detected in the peritoneal macrophages but not in the nonadherent draining lymph node cells in in vitro tests. On the other hand, nonadherent draining lymph node cells from the tumor-bearing mice, when mixed with C. parvum-induced macrophages, exhibited a specifically potentiated antitumor effect. In addition, this effect was completely abolished by treatment of the draining lymph node cells with anti-Thy-1 and complement. Thus, the potentiated antitumor effect following intratumor injection of C. parvum may be ascribed to the collaboration of specifically sensitized T-lymphocytes with C. parvum-activated macrophages.
给携带甲基胆蒽纤维肉瘤的BALB/c小鼠瘤内注射0.5毫克短小棒状杆菌后,显示出一种高度肿瘤特异性移植抗原,该抗原能特异性增强对后续肿瘤攻击的伴随免疫。这种增强的抗肿瘤免疫在Winn试验中可通过来自荷瘤小鼠的整个引流淋巴结细胞局部转移给正常受体,但当从这些细胞中去除贴壁细胞时,增强效果消失。此外,在体外试验中,在腹腔巨噬细胞中检测到对肿瘤细胞的增强的细胞抑制作用,但在非贴壁引流淋巴结细胞中未检测到。另一方面,来自荷瘤小鼠的非贴壁引流淋巴结细胞与短小棒状杆菌诱导的巨噬细胞混合时,表现出特异性增强的抗肿瘤作用。此外,用抗Thy-1和补体处理引流淋巴结细胞可完全消除这种作用。因此,瘤内注射短小棒状杆菌后增强的抗肿瘤作用可能归因于特异性致敏T淋巴细胞与短小棒状杆菌激活的巨噬细胞的协同作用。